Leaving behind your assets comes with some risk, potentially higher fees and fewer investment options.
More Stories
Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices
The CEO of Novo Nordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday, as...
Buy this REIT’s stock to make money on the rapid aging of America’s population
The baby-boomer generation is “fast marching into retirement,” and BofA Securities picked out a stock investors can buy to benefit...
Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial
Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular dystrophy.
As Visa’s stock drops, here’s why a possible antitrust case could be so worrying
There are more potential alternatives to Visa’s debit network in the event the company is penalized by the Justice Department.
67 million Medicare recipients face ‘chaos’ if Congress cuts telehealth benefits
Elderly and disabled patients could miss out on healthcare services unless an extension is passed before the end of the...